These U.S. companies are scheduled to report their quarterly earnings for the fiscal 2014 and 2015 today. Below is a preview of their key earning metrics, based on consensus estimates of analysts polled by Bloomberg. We have also provided analysts’ consensus buy ratings for these stocks with upside/downside potential for the upcoming 12-months.
| Company | Ticker | Exchange | Market Cap (MM) |
Last Price | Industry | Reporting Time |
Quarter | Sales ($MM) (Growth) |
Net Income ($MM) (Growth) |
EPS ($) (Growth) |
Total Analyst Coverage |
Buy Rating | Upside Potential |
| Joy Global Inc | JOY | NYSE | 4,521.0 | 46.05 | Machinery-Constr&Mining | 06:00 | Q4’14 | 1054.20 (-10.8%) |
108.20 (303.2%) |
1.14 (356.0%) |
23 | 30% | 29% |
| Jabil Circuit Inc | JBL | NYSE | 3,804.5 | 19.69 | Electronic Compo-Misc | 16:02 | Q1’15 | 4463.40 (-0.6%) |
51.80 (11.4%) |
0.34 (11.8%) |
13 | 31% | 12% |
| Herman Miller Inc | MLHR | NASDAQ | 1,791.1 | 30.11 | Office Furnishings-Orig | 16:00 | Q2’15 | 467.00 (6.5%) |
-89.10 (-1059.5%) |
-1.50 (-1078.6%) |
5 | 100% | 23% |
| Apogee Enterprises Inc | APOG | NASDAQ | 1,215.6 | 41.97 | Bldg Prod-Doors&Windows | AMC | Q3’14 | 204.00 (4.7%) |
9.30 (20.1%) |
0.35 (17.9%) |
6 | 67% | 17% |
| Eagle Pharmaceuticals Inc/DE | EGRX | NASDAQ | 175.5 | 12.52 | Medical-Drugs | BMO | Q4’14 | 2.60 (NA) |
-6.98 (NA) |
-0.49 (NA) |
4 | 75% | 105% |
| Luby’s Inc | LUB | NYSE | 136.8 | 4.72 | Retail-Restaurants | AMC | Q1’15 | 459.00 (9.9%) |
NA (-830.7%) |
0.01 (-600.0%) |
2 | 50% | 6% |
| Biodel Inc | BIOD | NASDAQ | 29.5 | 1.30 | Medical-Drugs | 16:00 | Q4’14 | 0.00 (NA) |
-5.58 (-584.3%) |
-0.25 (-604.0%) |
5 | 80% | 131% |
Note: Sales, Net Income & EPS are Bloomberg estimated figures and the growth rates mentioned are year-over-year.
AMC: After Market Close
BMO: Before Market Open
NA: Not Available
NA: Not Meaningful
